JESSICA BRUZZICHESI: Open Payments
NPI 1386179976 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 42 payments from 11 companies in 2025. Trend: 2023 $251 · 2024 $545 · 2025 $903
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $201 |
| ABBVIE INC. | 10 | $174 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| Alkermes, Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Almatica Pharma LLC | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: AUSTEDO XR, VRAYLAR, REXULTI, ARISTADA, CAPLYTA, Auvelity, LOREEV XR, SPRAVATO.
Industry payments across FL — which companies pay providers there.
